Skip to main content
Premium Trial:

Request an Annual Quote

RayBiotech to Help Banner Sun Health Investigate Neurodegenerative Disease Biomarkers

NEW YORK (GenomeWeb News) – RayBiotech said late Thursday that it has executed a master services agreement with Banner Sun Health Research Institute for the analysis of biomarkers of neurodegenerative disorders.

Under the agreement, RayBiotech will provide services for the analysis of biomarkers with a particular focus on ailments such as Alzheimer's and Parkinson diseases. The company's platform can be used to evaluate both the identity and quantity of biomarkers in a comprehensive, high-throughput manner, it said.

Financial and other terms of the deal were not disclosed.

"We believe that the collaboration will yield promising new opportunities facilitating early diagnosis of these devastating diseases," RayBiotech COO and Co-founder Rani Huang said in a statement.

The company is based in Norcross, Ga., and develops antibody and protein array technologies. Banner Sun Health is a biomedical research center headquartered in Sun City, Ariz. It conducts basic and translational research, as well as clinical research, into normal aging and certain age-related illnesses.

The Scan

Transplant Tests Edited Pig Kidneys

The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient.

UK Changes Some Gene-Edited Crop Rules

A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says.

Pill Works Against Omicron in Lab

Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports.

Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas

In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.